Covax, a global initiative in times of crisis; The aim is to distribute the corona vaccine fairly to all countries in the world, rich and poor alike. Under the auspices of the World Health Organization (WHO) with the support of the United Nations, it is planned to provide 200 crore free doses of vaccine to the poor countries by the end of this year. With this, it is possible to vaccinate about one-fourth of the people in these countries. Bangladesh is also expected to receive 1 crore 9 lakh 8 thousand vaccines from Kovacs by next June.
Covacs means Covid-19 Vaccines Global Access Facility. In addition to the WHO, under its joint leadership, there is the global low-cost vaccine initiative Gavi, the International Cooperation Agency for the Development of Infectious Diseases (CEPI). In the meantime, 198 countries have joined the initiative, according to the WHO.
Corona infections are on the rise around the world. In Europe, South America, South Asian countries are breaking records every day. In this situation, as the demand for vaccines has increased, so has the uncertainty about getting vaccines on time. Therefore, experts believe that ambitious global initiatives such as Covax to curb the ongoing epidemic and to ensure fair availability of vaccines to the rich and the poor may face a number of challenges. A UN News report published on Sunday highlighted these challenges.
At the beginning of the epidemic, UNICEF stockpiled 500 million syringes outside the producing countries. In response, producing countries imposed restrictions on syringe exports. The price of syringes goes up as the supply decreases. Now the same situation is likely to occur with the corona vaccine.
This situation is being seen as ‘vaccine nationalism’ or ‘vaccination nationalization’. This means that producing countries will first ensure vaccination for their own people. Only then will it export. Since vaccine production is limited to a few countries, restrictions on exports could deprive people in most countries of the world of access to vaccines. The Kovacs initiative could face challenges.
The WHO has already warned about the matter. According to the agency, the “nationalization” could prolong the fight against the epidemic if control of the corona vaccine exports is curtailed, which will affect people’s lives and the economy.
The solution may be to allow poorer countries to produce vaccines locally. Provide support and technology to enhance capacity. Diane Abed-Vargara, communications chief for the Kovacs project, said the WHO would help countries increase their capacity to acquire or produce vaccines and acquire technology. This will reduce the dependence of poor countries in Africa, Asia and South America for vaccination.
There are a number of tasks, from transporting the vaccine by plane from the producing countries to controlling the required temperature. After that, proper distribution of vaccines will have to be done in different parts of the country. Analysts say this stage is the most challenging. This is because in the marginal areas of poor countries, if there are not enough facilities for storage and delivery of vaccines, there will be inequality in the distribution of vaccines. Huge numbers of people will be deprived of vaccinations.
EF’s Global Covacs Coordinator, said Ghana had received its first vaccine from Covacs. The country has shown great success in the smooth distribution of vaccines. However, many West African countries do not have good facilities and human resources like Ghana. In these countries, vaccination activities are more likely to be city-centric. As a result, fair distribution will not be ensured.
The UNICEF official added, “We want to ensure that everyone is vaccinated. In many countries it is limited to urban and frontline fighters. Many people will not get vaccinated. The main purpose of vaccination will be disrupted.
The CoVAX project will require ৩ 3.2 billion in 2021 to buy the corona vaccine for more than 190 countries, said Diane Vargara. However, poor countries will get these vaccines free of cost. However, getting this vaccine is not the last word. There is a lot of work to be done to preserve, store and distribute it. Immunizers need to be trained. These works will also require huge amount of money.
The vaccination project basically requires allocation in two stages. First, buy vaccines. Second, to advance various management projects to reach those vaccines to the users. Since poorer countries will get free vaccines from Kovacs, they will not have to spend in this sector. But those vaccines have to reach the hands of ordinary people at their own expense. It will cost a lot. The United States, the United Kingdom, and the European Union have reduced the cost of vaccination and its management.
Ivory Coast is the second country after Ghana to receive coronavirus vaccine from Kovacs. February 26, Abidjan
Ivory Coast is the second country after Ghana to receive coronavirus vaccine from Kovacs. February 28, Abidjan Photo: Reuters
UNICEF says the poorest 92 countries will need an additional কোটি 2 billion to manage frozen vaccines, train vaccinated health workers, and buy fuel for vaccinated trucks, which are difficult for these countries to afford. The agency called on donors to provide কোটি 51 million in immediate humanitarian assistance.
Trending stocks of rich countries
Poor countries are worried about getting vaccinated. Many countries are limited